Purpose. To assess surgical results and morbidity of tumor enucleation (TE), and to evaluate their correlation with PADUA nephrometric score. Methods. We prospectively gathered data, including accurate analysis of tumor nephrometry, from 244 consecutive patients treated with TE for clinically localized renal cell carcinoma. All surgical results were collected, and perioperative complications were stratified for severity according to Clavien system. Correlation between preoperative variables and surgical results/complications was assessed with uni-and multivariate analysis. Results. Mean (range) tumor size was 3.6 (0.8-10.0) cm, and mean (range) warm ischemia time was 16.8 (5-35) min. Overall, perioperative complications occurred in 45 patients (18.4 %), and of those 8 were medical and 37 were surgical (4 Clavien grade 1, 25 grade 2, and 8 grade 3) complications. Urine leakage rate was 2.0 %. No grade 4/5 complications occurred in this series. At univariate analysis PADUA score, endophytic tumor growth, tumor diameter, involvement of UCS and renal sinus resulted associated with warm ischemia time (p \ 0.0001 each) and surgical complications (p = 0.0007, p = 0.049, p = 0.021, p = 0.036, and p = 0.029, respectively). At logistic regression, nephrometry score resulted independently associated with overall complications (related risk for each increased point 1.54; p = 0.017), surgical complications (related risk 1.58; p = 0.016), and Clavien grade 3 surgical complications (related risk 2.99; p = 0.008). Conclusions. The TE technique was associated with a 15.2 % surgical complication rate with a 3.3 % reintervention rate (including ureteral stenting and superselective renal artery embolization). Tumor nephrometry and surgical indication resulted independent predictors of Clavien grade 3 complications. The PADUA score is a reliable tool to predict surgical results and morbidity of TE.
accurately assess surgical results and predictors of perioperative complications of TE, using the modified Clavien system, and to provide an external validation of PADUA score for the TE technique.
MATERIALS AND METHODS

Patient Selection
Between July 2007 and March 2011 we prospectively gathered data from 244 consecutive patients treated with open TE for localized RCC. This study was approved by the local ethics committee, and informed consent was collected for all patients.
Surgical Technique
A lateral retroperitoneal approach was used for all patients. For prevention of ischemic renal damage, all patients were infused with mannitol a few minutes before arterial occlusion. The renal pedicle was usually controlled en bloc with a vascular clamp before TE. Alternatively, manual compression was used in case of polar lesions and according to surgeon's preference. Because our warm ischemia time (WIT) is usually under 25 min, cold ischemia was never used in this period. 3, 4, 8 TE was done according to our previously described technique, by blunt dissection of the natural cleavage plane between the tumor capsule and normal parenchyma. 3, 4 Bleeding vessels and incidentally opened calyces were sutured with 4-0 monofilament running sutures. Energy sources in the surgical bed and intraoperative frozen section were not used during this period. The parenchymal defect was closed with horizontal interrupted sutures after apposition of hemostatic agents (usually FloSeal and/or Tabotamp).
Data Collection
The following patient characteristics were include in the database: gender, age, body mass index (BMI), American Society of Anesthesiologists (ASA) score, Eastern Cooperative Oncology Group (ECOG) grade, Charlson index, and surgical indication which was registered as imperative, relative or elective. All patients were staged preoperatively with computed tomography (CT) or magnetic resonance imaging. Among the anatomical parameters included in the PADUA score, the clinical tumor size (B4 cm, 4.1-7 cm, or [7 cm ), the polar location (superior/inferior or middle), the rim location (lateral or medial), the degree of tumor deepening into parenchyma (C50 % exophytic, \50 % exophytic, and entirely endophytic), the involvement of the UCS (not involved or dislocated/infiltrated), and the face of the kidney involved (anterior or posterior) were prospectively included in our database since 2006. 8 At contrary, data on tumor relationship with renal sinus (not involved or involved) were retrospectively recorded after a review of preoperative imaging and/or operative records. The PADUA subscores were assigned in consensus by two urologic surgeons (A.M., G.V.). 9 The following surgical data were recorded: use of pedicle clamping, WIT, total operative time, estimated blood loss (EBL), and the length of hospital stay (LOS) including the date of surgery. Pathological tumor size, tumor extension according to tumor, node, metastasis staging system classification, nuclear grade according to Fuhrman system, and histological subtypes according to World Health Organization classification were also recorded. [13] [14] [15] All the perioperative (including intra-and postoperative) medical and surgical complications, occurring during surgery and within 30 days, were recorded. The severity of surgical complications was graded according to the modified Clavien system. 16 Postoperative blood loss was registered in case of reduction [2.5 g/dL in hemoglobin level, and the need of blood transfusions, superselective embolization of renal artery or of reintervention was recorded. Urinary fistula was recorded if there was persistent leakage from the drainage beyond VI postoperative day, and a biochemical analysis of the drain fluid consistent with urine (drainage fluid-to-serum creatinine ratio greater than two). Ureteral stenting was limited to urinary fistula with persistent leakage beyond X postoperative day. Deep venous thrombosis was diagnosed with ultrasound-Doppler, and pulmonary embolism by spiral CT.
Statistical Analysis
Parametric continuous variables are presented as mean ± standard deviation (SD) and range, while nonparametric variables as median and interquartile range (IQR). PADUA score was analyzed both as binary (\10 vs. C10) and as nonparametric continuous (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) invasive procedure in 5 (2.1 %). Urinary fistula occurred in 5 patients (2.0 %); it was treated with drainage manipulation in 2 (0.8 %), while it needed ureteral stenting in three cases (1.2 %). According to Clavien system, four surgical complications were grade 1 (1.6 %), 25 grade 2 (10.2 %), and 8 grade 3 (3.3 %). No grade 4 and 5 surgical complications occurred. Medical complications, including thromboembolism and heart failure, were not stratified for severity but included in the analysis of overall complications.
Tumors' anatomical and pathological characteristics are summarized in Table 2 . The mean (range) clinical tumor Acute heart failure 5 (2.1 %) 3 (1.6 %) 2 (3.8 %)
PADUA preoperative aspects and dimensions used for anatomical classification of renal tumor, ECOG Eastern Cooperative Oncology Group, IQR interquartile range, NSS nephron-sparing surgery, SD standard deviation size was 3.6 (0.8-10.0); median PADUA score was 8 (IQR 7-9), and 21.3 % of patients had PADUA C10. At pathological assessment, 34 (13.9 %) patients had benign tumors. Of the 210 malignant lesions, pathological stage was pT1a in 156 cases (74.3 %), pT1b in 31 (14.8 %), pT2 in 4 (1.9 %), and pT3a in 19 cases (9.0 %). Positive surgical margin rate was 1.6 %.
We assessed variables associated with complications; the results of univariate analyses are presented in Table 3 . The entirely endophytic tumor growth, the involvement of UCS and renal sinus, the clinical diameter and the PADUA score were significantly correlated with WIT and EBL. Only PADUA score and surgical indications resulted significantly associated with operative time. Clinical tumor diameter, surgical indications, Charlson index and PADUA score were significantly correlated with overall complications (p = 0.042, p = 0.045, p \ 0.0001, and p = 0.004, respectively). Significant predictors of surgical complications resulted the entirely endophytic tumor growth (p = 0.049), the involvement of UCS (p = 0.029) and renal sinus (p = 0.036), the tumor diameter (p = 0.021) and the PADUA score (p = 0.0007). The involvement of renal sinus and UCS, the PADUA score and the surgical indications were also significantly correlated with Clavien grade 3 surgical complications (p = 0.006, p = 0.026, p = 0.0004, and p = 0.019, respectively).
The results of multivariate analysis are summarized in Table 4 . The PADUA score (related risk [RR] 1.54; p = 0.017) and the surgical indication (RR = 2.59; p = 0.019) resulted independently associated with overall perioperative complications. Each point increase in PAD-UA score was related with a 1.54-fold increase in the risk of complications after TE. Moreover, the PADUA score Positive surgical margins 4 (1.6 %)
PADUA preoperative aspects and dimensions used for anatomical classification of renal tumor, NSS nephron-sparing surgery, SD standard deviation, UCS urinary collecting system was found to be the only anatomical variable independently correlated with surgical complications (RR = 1.58; p = 0.016). Finally, PADUA score (RR = 2.99; p = 0.008), the surgical indication (RR = 7.28; p = 0.029) and the tumor relationship with renal sinus (RR = 3.85; p = 0.038) were independently associated with Clavien grade 3 surgical complications. Patients with a score C10 had a 5.9-fold and 9.7-fold higher risk of overall complications and surgical complications, respectively, compared to those with scores of 6-7 (data not shown). After excluding the PADUA score from multivariate analysis (Table 5) , no single anatomical variable correlated independently with surgical complications, whereas only the renal sinus involvement correlated with the Clavien grade 3 surgical complications.
The mean (range) follow-up was 29 (12-53) months. Overall, 6 of 244 (2.5 %) patients experienced progressive disease, 2 (0.8 %) of whom had local recurrence alone, 1 (0.4 %) had local recurrence associated with distant metastases. The remaining 3 (1.2 %) patients had distant metastases with no evidence of local recurrence. From baseline to last follow-up in March 2012, 10 patients died, 2 of whom died of RCC, and 8 of causes independent from renal tumor. All the variables used for this analysis were significant at univariate analysis (Table 3) PADUA preoperative aspects and dimensions used for anatomical classification of renal tumor, UCS urinary collecting system
DISCUSSION
Many studies have investigated the oncological results of the TE technique, demonstrating local recurrence-free survival and cancer specific survival rates comparable to those reported after standard PN, for renal tumors with clinical diameter up to 7 cm. 3, 4, 7 In the last few years an increasing number of centers started to use this technique, aiming to maximize healthy parenchyma preservation and theoretically reduce the incidence of complications. [6] [7] [8] 17 Indeed, in previous retrospective reports the most common surgical complications of TE requiring reintervention (grade 3) were urinary fistula requiring JJ stent positioning, ranging between 1.4 and 3.3 %, and postoperative bleeding requiring superselective embolization of renal artery, ranging between 0 and 7 %, respectively. 1, 3, 4, 18 The only prospective report on TE complications, published to date, confirmed the low incidence of these two events, occurring in 0.5 and 2 % of cases, respectively. 8 In the present series the incidence of urinary fistula requiring ureteral stent and severe perioperative bleeding, requiring a second conservative procedure are 1.2 and 2.1 %, respectively. These data compare favorably with the rates reported after standard PN in the best available evidence, that is 4.4 % for urinary fistula and 3.1 % for severe postoperative bleeding. 19 It is difficult to draw significant conclusions on the differences in complication rate between the two techniques and we cannot confirm that TE is associated with a lower rate of major bleeding and urinary fistula as suggested by others. 20 So far only one retrospective study on a very limited number of patients compared the two techniques, concluding that no significant differences exist between TE and PN regarding morbidity and mortality. 21 Only a large prospective comparative study will answer to this question in the future. Currently a limitation would reduce the methodological accuracy of such studies: no RCC nephrometry score has been validated for TE, to date. Therefore, the validation of the PADUA score, or other nephrometric tools, for TE seems a necessary step.
In the original study PADUA score was able to predict the risk of overall complications in patients treated with open PN without clamping of renal pedicle. In terms of amount of patients, age, gender, clinical tumor diameter, comorbidity index, and the PADUA sub-classification, our series is comparable to the original study. Whereas, we acknowledge three main differences: first, the tumors were removed by blunt excision with no visible rim of healthy parenchyma around it. Second, we used ischemia in the large majority of patients. To operate in a bloodless field is of critical importance during the blunt dissection of the enucleation plane, that lies between healthy parenchyma and tumor capsule. However, others showed that TE can be done without clamping the renal vessels.
2 Third, we also correlated PADUA score with surgical complications and Clavien grade 3 surgical complications, as we found in a previous analysis a strong correlation between tumor nephrometric features and severe bleeding and urinary fistula. 8 In the present analysis we can confirm that the correlation of PADUA with surgical complications resulted stronger compared to overall complications, which certainly are affected by the medical adverse events. It is logical that an unfavorable nephrometry had a direct relationship to increased risk of bleeding and urine fistula, while had only an indirect correlation with medical complications-for example, due to prolonged operative time, longer WIT, or increased bleeding. Anyway, further studies are needed to analyze the association between RCC nephrometry and the type and severity of medical complications.
In our study overall, surgical, and Clavien grade 3 complication rates were 18.4, 15.2 and 3.3 %, respectively. At univariate analysis the exophytic rate, the involvement of renal sinus and UCS, the clinical tumor diameter and the PADUA score correlated significantly with WIT, EBL and the surgical complications. Nevertheless no anatomical parameters of PADUA score, including the tumor diameter, individually maintained the significance at multivariate Variables examined are all the anatomical PADUA subscores analysis to predict surgical complications (Table 5) , and PADUA score only was independently associated with surgical complications (Table 4 ). This result suggests that the overall nephrometry of RCC is more important than any single anatomical feature in predicting the risk of surgical complications. Each point increase in PADUA score was associated with a 1.58-fold increased risk of surgical complications, and with a 2.99-fold increased risk of Clavien 3 surgical complications. In our series patients with score C10 had a 5.9-fold higher risk of overall complications compared to those with scores of 6-7, while Ficarra reported a 30-fold increased risk in this clinical setting. 9 This can be partially justified by the different definition of complications and by the different attitude on the vascular pedicle (clamping vs. no clamping), but we cannot exclude that these two techniques had different incidences of complications when they face tumors with most unfavorable nephrometry. Comparative studies between TE and PN would be advisable also in order to investigate whether a subgroup of renal tumors, for anatomical features, would benefit most from the TE technique rather than the standard PN.
In our study the lack of a control group treated with standard PN may appear a limit but, as expressed above, a comparative study of TE versus PN requires two groups with comparable nephrometry score with the same anatomical classification and therefore might be addressed to future studies, after the present validation of PADUA.
In our center we use TE as the standard technique for conservative treatment of RCC with clinical diameter up to 7 cm. 3, 4 TE has proven to ensure excellent local control as, even in case of tumor capsule penetration, neoplastic cells are separated from the surgical margins by a thin layer of normal tissue. 5 In the present series the incidence of positive surgical margins (PSM) was 1.6 %, well within the range of 0-7 % reported in the literature. This low incidence of PSM after TE confirms the data presented in the SATURN comparative study showing a negligible PSM rate after TE, that was even lower than after PN. 7 For these reasons we do not advocate the use of intraoperative frozen sections. In our series we have a minority of pT2 and pT3a tumors. This is because over 90 % of clinical T1a and over 50 % of T1b are treated conservatively with TE and few of them may have initial infiltration of the perirenal fat at the pathologic assessment, without the possibility of prediction.
However, in some cases the local progression of RCC has been underestimated by preoperative imaging, and intraoperatively the tumor infiltration beyond the pseudocapsule in either intrarenal vein branches, or in the UCS or in the perirenal fat was macroscopically found. These findings contraindicate the conservative surgery (both TE and PN) and the procedure was converted to radical nephrectomy. This occurred for seven patients, who were not included in the present series of TE because the conversion was done for oncological reasons and not due to intraoperative complications.
This study evaluated only patients treated with open surgery, but TE can also be done by laparoscopy and robotics, so the lack of these assessments can be a limitation of this study. Ourselves and others should validate PADUA classification for TE using different approaches. Another potential drawback of this study is the validation of the PADUA score only, not evaluating other anatomical classification such as the C-Index or R.E.N.A.L score. 22, 23 Compared to C-Index, we found PADUA score easier to assign, because it does not require a software for the crosssectional imaging assessment. Furthermore, while considering the RENAL a satisfactory and simple system, we used PADUA score because it includes as separate variables the involvement of the renal sinus and the involvement of the UCS, that we consider differently related to the degree of complexity of conservative surgery. Indeed, in our analysis the renal sinus involvement was the only anatomical variable who, by itself, resulted independently correlated to Clavien grade 3 surgical complication. The validation of RENAL score as well as the comparison between RENAL and PADUA score for TE will be addressed in future studies.
In conclusion, the TE technique was associated with a 15.2 % surgical complication rate and of those only 3.3 % required reintervention (grade 3). Ureteral stenting for urinary fistula was needed in 1.2 %, a second conservative procedure for severe hemorrhage in 2.1 %. Anatomical features, including PADUA score, endophytic tumor growth, tumor diameter, involvement of UCS and renal sinus resulted associated with WIT, EBL, and surgical complications. Only the total nephrometry score resulted independently associated with surgical complications.
CONFLICT OF INTEREST None.
